Which are the causes of Blackfan Diamond Anemia DBA?

Diamond-Blackfan Anemia (DBA) is a rare inherited bone marrow failure syndrome primarily caused by mutations in genes involved in ribosomal protein synthesis. These genetic errors disrupt the production of red blood cells, leading to severe anemia, and while the underlying genetic mechanisms are well-identified in about 80% of patients, research into the remaining cases and environmental modifiers is ongoing.

What are the primary genetic causes of Diamond-Blackfan Anemia?

The core cause of Diamond-Blackfan Anemia is a defect in the machinery the body uses to build proteins—specifically, the ribosomes. Think of ribosomes as the cell's "protein factories." In patients with Diamond-Blackfan Anemia, mutations in genes encoding ribosomal proteins cause these factories to malfunction, which is particularly toxic to developing red blood cells in the bone marrow. To date, pathogenic variants in at least 20 different genes, such as RPS19 (the most common, found in approximately 25% of cases), RPL5, and RPL11, have been linked to the development of Diamond-Blackfan Anemia.

Is Diamond-Blackfan Anemia hereditary?

Yes, Diamond-Blackfan Anemia is typically an inherited condition, though it can occur sporadically. Inheritance patterns include:

• Autosomal Dominant: The most common pattern, where a single copy of a mutated gene is sufficient to cause the disease.


• Autosomal Recessive: A rarer pattern where both parents must carry the mutation.


• De novo mutations: In many instances, the genetic mutation occurs for the first time in the affected individual, meaning neither parent carries the faulty gene.

Are there environmental or non-genetic triggers?

Currently, there is no evidence suggesting that Diamond-Blackfan Anemia is triggered by external environmental factors, infections, or diet. Unlike some other forms of anemia, this is a strictly constitutional (genetic) disorder. While 8 individuals in the DiseaseMaps.org community share their experiences with Diamond-Blackfan Anemia, their stories emphasize that the condition is intrinsic to the patient's genetic code rather than a result of lifestyle or environment.

What does current research focus on?

Medical researchers are currently investigating why some individuals with the same genetic mutation experience different symptoms, a phenomenon called variable expressivity. Ongoing studies are exploring how "modifier genes" and cellular stress responses might influence the severity of Diamond-Blackfan Anemia. Understanding these pathways is essential for developing future therapies that go beyond current treatments like corticosteroids or bone marrow transplants.

Next steps

• Consult with a clinical geneticist to discuss genetic testing and family counseling options.


• Connect with the 8 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Monitor the Diamond Blackfan Anemia Foundation (DBAF) website for the latest clinical trial information.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Diamond-Blackfan Anemia.


• Orphanet: Diamond-Blackfan Anemia (ORPHA:98).


• OMIM (Online Mendelian Inheritance in Man): Diamond-Blackfan Anemia Entry #105650.


• Diamond Blackfan Anemia Foundation (DBAF): Clinical research and patient resources.